financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Market
financetom
/
Market
/
Buy Sun Pharma, Cipla, DRL, Ashok Leyland & Cholamandalam, says VK Sharma
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Buy Sun Pharma, Cipla, DRL, Ashok Leyland & Cholamandalam, says VK Sharma
Sep 3, 2018 12:16 AM

The latest analysis and commentary by stock market guru VK Sharma of HDFC Securities on what is moving the markets today. Check out his top stock recommendations.

He spoke at length about Ashok Leyland, Cipla, Cholamandalam Investment and Finance Company, Dr Reddy’s Laboratories (DRL) and Sun Pharma.

Disclaimer:

The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.

First Published:Sept 3, 2018 9:16 AM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tata Motors shares cross ₹700 mark for first time, hit record high ahead of Tata Tech listing
Tata Motors shares cross ₹700 mark for first time, hit record high ahead of Tata Tech listing
Nov 29, 2023
The rally in the Tata Motors stock comes ahead of the listing of its arm Tata Technologies Ltd on the bourses. Last heard, shares of Tata Technologies were trading at a premium of ₹420 in the grey market, suggesting a likely listing at ₹920 over its issue price of ₹500.
 Reliance, PCBL and more: Wednesday's top brokerage calls
Reliance, PCBL and more: Wednesday's top brokerage calls
Nov 28, 2023
JPmorgan has maintained an 'overweight' rating on Reliance with a target of Rs 2,810 per share, while UBS has maintained a 'neutral' rating on Simens with a target of Rs 3,750 per share.
Fedbank Financial headed for flat to negative listing? Here's what grey market premium indicates
Fedbank Financial headed for flat to negative listing? Here's what grey market premium indicates
Nov 29, 2023
Fedbank Financial Services IPO listing date: Despite the NBFC's strong track record of growth and profitability, along with its diversified customer portfolio, the lack of enthusiasm among investors could lead to a flat or even negative listing, analysts say.
 PSU Alert: BHEL shares now up 100% for 2023; Co signs contract with defence ministry
PSU Alert: BHEL shares now up 100% for 2023; Co signs contract with defence ministry
Nov 29, 2023
BHEL Share Price: The stock has been on an upward swing since November 22, and has gained  14% in the last five trade sessions. It has gained 105% this year, so far.
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2026 - www.financetom.com All Rights Reserved